Curetis

The Unyvero platform developed by Curetis is a fast, comprehensive diagnostics system for severe infectious diseases in hospitalized patients.

Using a variety of cartridges, diseases such as pneumonia or implant and tissue infections can be easily and rapidly diagnosed within just 4–5 hours, whether this is in the hospital laboratory or directly at the "point of need" in the intensive care unit. Curetis completed its IPO in November 2015 at Euronext Amsterdam.